DZIF Bonn-Köln, Deutschland

🦠 EHA-SWG Infections in Hematology Webinar
📅 March 2, 2026 | 16:00 CET
🎤 @salmantongarcia.bsky.social
Insights from the EPIAMLINF registry on infections in AML patients – epidemiology, outcomes & clinical impact.
👉 Register now! ehaweb-org.zoom.us/meeting/regi...

🚨 IATA-Gefahrgutschulung am 25.03.2026 in Köln @zks-koeln.bsky.social ! 🌍 Für den sicheren Versand von humanen Proben & infektiösen Stoffen. Noch wenige Plätze frei! Jetzt anmelden: zks.uni-koeln.de/akademie/iat... #IATA #Gefahrgut #KlinischeForschung

HIV antibody opens new approaches for vaccine development and combination therapies | German Center for Infection Research An international research team has identified a novel

🔬 A key step toward improved #HIV treatments and vaccine development: DZIF researchers have identified a novel HIV antibody, 007, which targets a particularly vulnerable site on the virus and overcomes the limitations of classical antibodies.

#HIVResearch @uniklinikkoeln.bsky.social

We are excited to welcome everyone at our DZIF/PEG Joint Meeting 2026 in Bonn!

We look forward to insightful talks, engaging discussions and poster sessions that will drive infection research and translation forward.

Enjoy the conference #DZIFPEG2026 #UnitedAgainstInfections

In the spirit of our #DZIFPEG2026 Joint Meeting, we would like to honor the commitment of Prof. Maura Dandri and Prof. Hans-Georg Kräusslich as outgoing members of the DZIF Executive Board👏

We are grateful for their contributions and look forward to continuing our work within the DZIF network.

At PRISMA Congress, @salmantongarcia.bsky.social presents "The evolving challenge of fungal resistance", highlighting the latest developments and emerging clinical challenges in antifungal resistance. #PRISMA2026 #FungalResistance

Honored to host Prof. Ruoyu Li & Prof. Yinggai Song at our ECMM Excellence Center Cologne. From Cologne Cathedral to TRIO lab, insightful discussions & guided tours. Looking forward to future collaborations!

Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report To determine long-term immunogenicity and reactogenicity of different SARS-CoV-2 mRNA-vaccines in a population ≥75 years in a randomized trial.Partici…

Final EU-COVAT-1-AGED results:
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE

🦠📊 RKI veröffentlicht erstmals Resistenzdaten zu Pilzen.
Neue ARS-Daten zeigen Resistenzentwicklungen bei Candida spp. und Aspergillus fumigatus in Deutschland. Ein wichtiger Schritt für Therapie & Surveillance.
🔗 amr.rki.de/Content/Date...
#AMR #Pilzresistenzen #RKI

I’m speaking at #ISHAMAsia2026 in Kuala Lumpur (Sept 9–12).
Join leading experts in medical mycology for the latest research and clinical insights.
See you in KL!
isham.asia
#MedicalMycology #ThinkFungus

DGI warnt vor Schwächung der Infektionsmedizin Die DGI warnt vor einer Schwächung der Infektionsmedizin durch eine Streichung der Leistungsgruppe Infektiologie.

⚠️ Die DGI warnt vor einer Schwächung der #Infektiologie.
Neue Daten zeigen: Adipositas erhöht das Risiko für schwere Infektionen deutlich. Infektiologische Expertise rettet Leben, senkt Komplikationen & Kosten – ihre Streichung wäre ein Rückschritt.
👉 biermann-medizin.de/dgi-warnt-vo...

Von Schnelltests bis zu Impfstoffen – klinische Studien sichern Gesundheit und retten Leben. Freiwilligen-Register (v-reg) für freiwillige Teilnahme: v-reg.eu

#Medizin #FreiwilligenRegister #Zukunft

Immer weniger Menschen lassen sich gegen Grippe impfen Die Grippeimpfquote bei über 60-Jährigen ist auf einen Tiefstand seit der Corona-Pandemie gefallen, wie aktuelle Daten der Barmer-Krankenkasse zeigen. Nur 40,8 Prozent wurden 2023 geimpft, weit entfer...

„Dramatisch zu niedrig“ – nur 40,8 % der über 60-Jährigen ließen sich 2023 gegen Grippe impfen. Eine Impfung schützt besonders Ältere und Risikogruppen vor schweren Verläufen. Mehr Infos: www.rnd.de/politik/dram...
#Grippe #Impfung #Gesundheit #Prävention #60plus

Starker Vortrag gestern von PD Dr. Sibylle C. Mellinghoff zur Dauer des Pneumokokken-Schutzes bei Hämodialysepatient:innen (DOPPIO-Studie) beim gemeinsamen DZIF/PEG-Meeting 2026. Großartige Wissenschaft, echte Relevanz!
#InfectiousDiseases #DZIF #PEG #Vaccination

Spannender Vortrag von Laman Rahimli beim DZIF/PEG Meeting 2026: Outcomes invasiver Candida-Infektionen in Europa und den USA – erste Einblicke aus einer laufenden multinationalen Studie (2024–2026). Klinisch hochrelevant!
#Candida #InfectiousDiseases #DZIF #PEG #ClinicalResearch #Mycology

Mycology A-Z - YouTube Mycology A–Z is a multilingual video series that explores the fascinating world of fungi in a concise, accessible, and visually engaging way. The series is d...

We’re excited to host Mycology A–Z as a playlist on our YouTube channel! 🌍🍄
A multilingual video series making mycology accessible for students, professionals & curious minds worldwide. More episodes coming soon!
www.youtube.com/playlist?lis...
#Mycology #Fungi #ScienceCommunication #YoungISHAM

Zwei inspirierende Tage bei der Gemeinsamen DZIF/PEG-Jahrestagung 2026 in Bonn! 🧫🌍
Spannende Impulse zu Infektionsforschung, Resistenzen, Innovationen und globalen Herausforderungen. Großer Dank an alle Beteiligten.

#DZIF #PEG #Infektionsforschung #AMR #GlobalHealth #Science

Room 007. I can hear Gladys Knight singing License to Kill ... Fungi. Always wanted to know who 006 and 008 are - we’ll find out. Meanwhile in Leuven: ESCMID Antifungal Stewardship, led by Riina Richardson.
👉 www.escmid.org/education/co...

Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer - PubMed Comprehensive literature search and expert panel consensus confirm most of the key recommendations of 2014. New recommendations on the use of G-CSF in immunotherapy settings provide insight and support for day-by-day clinical decision making in the care of patients with cancer.

New AGIHO guideline update on G-CSF prophylaxis in adult cancer patients! Evidence-based recommendations incl. immunotherapy settings, biosimilars & risk stratification to support clinical decision-making.
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines

Honored to feature Prof. Arunaloke Chakrabarti in the ISHAM Pioneers in Mycology series. A deep dive into his impact on medical mycology, global challenges, and the future of fungal disease research. Watch the interview: www.isham.org/about-isham/...

Mark your calendars for the #AMR Science-Policy Forum at Education Friday during #ESCMIDGlobal2026. Open to all congress attendees, the programme features unique sessions designed to foster interactive, solution-oriented discussions. More info:
https://ow.ly/wIGk50Y60Ml

#IDSky #clinmicro

Last week’s #READI General Assembly in Madrid ❄️
Dr. Kerstin Albus and Dr. Johanna Brustkern represented WP5 Clinical Sites #Capability Building, strengthening #clinicaltrial site competencies across Europe to support inclusive, multi-centre research. Great energy – READI is in motion 🚀

MedFacts with Prof. Schmitt: Adult Vaccination YouTube video by IDIM IDIM

New episode of MedFacts with Prof. Schmitt 🎥
Clear, science-based insights into adult vaccination, based on the Vaccitutor Course. Short, accessible, and evidence-based vaccine facts.
Watch now ▶️ www.youtube.com/shorts/uTy3t...

Rezafungin: A New Echinocandin for Invasive Fungal Infections YouTube video by IDIM IDIM

🎥 New video!
Prof. @franbridi.bsky.social introduces rezafungin, a next-generation echinocandin, covering MOA, PK profile & clinical potential in invasive fungal infections.
👉 Watch now: youtu.be/4-rKQjsppOg

More videos coming soon!

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO) - PubMed Community-acquired respiratory viruses (CARV), such as influenza-, parainfluenza- or respiratory syncytial virus, pose a significant threat to immunocompromised patients with cancer. Following the COVID-19 pandemic, SARS-CoV-2 has now joined the ranks of endemic respiratory viruses and continues to …

New 2025 evidence-based guideline from AGIHO/DGHO on prevention, diagnosis & management of community-acquired respiratory viruses including COVID-19 in cancer patients. Read here: pubmed.ncbi.nlm.nih.gov/41563477/

Kerstin Albus & Johanna Brustkern from our Cologne team are in Madrid ❄️ for Day 1 of the #READI General Assembly – driving clinical research that truly reflects all populations and promotes equity, diversity, and inclusion.
#READI #GlobalHealth #HealthEquity #ImplementationScience

Repetitorium Internistische Intensivmedizin In diesem Werk findet sich das gesamte Spektrum der internistischen Intensivmedizin systematisch, leitlinienorientiert und praxisnah dargestellt.

Die 4. Auflage von „Internistische Intensivmedizin“ ist da: systematisch, leitlinienorientiert und praxisnah – ideal für Klinikalltag und Prüfungsvorbereitung.
📖 Mehr hier: link.springer.com/book/10.1007...
#Intensivmedizin #Klinik #Medizin

🎉 Wir freuen uns riesig mit dir, @rosannesprute.bsky.social !
Herzlichen Glückwunsch zur Fachärztin für Innere Medizin – eine großartige Leistung, die viel Einsatz und Ausdauer zeigt. Schön, dich im Team zu haben! ✨

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry Click on the article title to read more.

RSV poses high risk in adults with hematological malignancies. Study highlights the urgent need for higher vaccination coverage, faster diagnostics & improved therapies to reduce hospitalizations, secondary infections and mortality. Read: onlinelibrary.wiley.com/doi/10.1002/...

Auf der #NUMConvention2026 in Berlin stellen wir CanTEN vor: eine multizentrische, randomisierte Studie zur Verkürzung der Therapiedauer bei Candidämie. Ziel: gleiche Sicherheit, weniger Belastung für Patient:innen & System. #Infektiologie #NUM @ilanareinhold.bsky.social